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Abstract: Enterococcus faecalis is an opportunistic pathogen that has emerged as a major cause of
nosocomial infections worldwide. Many clinical strains are indeed resistant to last resort antibiotics
and there is consequently a reawakening of interest in exploiting virulent phages to combat them.
However, little is still known about phage receptors and phage resistance mechanisms in enterococci.
We made use of a prophageless derivative of the well-known clinical strain E. faecalis V583 to isolate
a virulent phage belonging to the Picovirinae subfamily and to the P68 genus that we named Idefix.
Interestingly, most isolates of E. faecalis tested—including V583—were resistant to this phage and we
investigated more deeply into phage resistance mechanisms. We found that E. faecalis V583 prophage
6 was particularly efficient in resisting Idefix infection thanks to a new abortive infection (Abi)
mechanism, which we designated Abiα. It corresponded to the Pfam domain family with unknown
function DUF4393 and conferred a typical Abi phenotype by causing a premature lysis of infected
E. faecalis. The abiα gene is widespread among prophages of enterococci and other Gram-positive
bacteria. Furthermore, we identified two genes involved in the synthesis of the side chains of the
surface rhamnopolysaccharide that are important for Idefix adsorption. Interestingly, mutants in
these genes arose at a frequency of ~10−4 resistant mutants per generation, conferring a supplemental
bacterial line of defense against Idefix.
Keywords: abortive infection; prophage; adsorption; Enterococcus; rhamnopolysaccharide
1. Introduction
Enterococci are ubiquitous Gram-positive facultative anaerobic bacteria that colonize the
mammalian gastrointestinal tract [1]. In particular, the two species Enterococcus faecalis and Enterococcus
faecium are part of the normal human gut microbiota and generally have no adverse effects on healthy
individuals. However, they also represent opportunistic pathogens that have emerged as a leading
source of nosocomial infections, particularly in immunocompromised patients [2]. E. faecalis and
E. faecium mostly cause urinary tract infections, peritonitis, bacteraemia, and endocarditis [2]. The
clinical importance of these bacterial species is directly related to their antibiotic resistance. The
rapid spread of clinical isolates resistant to last resort antibiotics such as vancomycin and daptomycin
has been of particular concern and associated hospital acquired infections have become a growing
problem [3].
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Virulent bacteriophages, i.e., viruses that infect and obligatorily lyse bacteria, have long held
promise to treat bacterial infections and combat multi-drug resistant (MDR) bacteria [4]. In the recent
years, the complete genome and phage cycle characteristics of a dozen virulent E. faecalis and E. faecium
phages have been reported, emphasizing the growing interest for phage therapy in the future [5–15].
However, similar to the phenomenon of antibiotic resistance, bacterial resistance to phage is also taking
place. For instance, mutations in the cell wall protein PIPEF were recently found to provide resistance
to two siphophages by limiting phage DNA entry in E. faecalis [16]. Apart from this, the modes of
defence of enterococci against phages largely remain a terra incognita.
Keeping in mind that, in most ecosystems, bacteria co evolve with a plethora of bacteriophages,
which imperatively depend on them for their reproduction, it is no surprise that bacteria invest efforts in
fighting against them. They deploy for this goal different functions that have been studied for decades
(reviewed in [17,18]), and still led to new discoveries [19–23]. The E. faecalis species, however, seems to
have few acquired and innate immune systems. The only common clustered regularly interspaced
short palindromic repeat (CRISPR)-CRISPR associated (Cas) locus found in E. faecalis isolates has lost
its cas genes, and two complete type II CRISPR-Cas systems occur variably across the species [24–26].
Furthermore, no restriction-modification (R-M) system is commonly found within the species, and
to date only a single type II R-M system has been described in three E. faecalis chromosomes [27,28].
Finally, no complete defense island system associated with restriction-modification was detected in
E. faecalis to date [22]. The relative scarcity of R-M and CRISPR-Cas systems in MDR strains may
facilitate plasmid-encoded antibiotic resistance genes acquisition [29,30].
Although less studied, phages themselves compete for their hosts on the bacterial battlefield [31].
Phage genes involved in anti-phage mechanisms are mainly found in temperate or defective prophages,
rather than in virulent phages. During the prophage state (where the temperate phage is stably
associated with its host), in addition to repressor-dependent immunity against similar phages, some
phage express genes conferring resistance to infection by more or less unrelated phages. These genes
can encode generalist functions such as R-M systems [32] or CRISPR-Cas loci [33], or specific ones. For
instance, the Escherichia coli temperate phage P2 has three genes, fun, tin, and old, preventing growth
of T5, T-even, and lambda respectively [34]. Furthermore, the O-antigen acetylase of Salmonella
typhimurium phage BTP1 is reported to prevent adsorption of other phages [35]. Other typical
prophage-encoded superinfection exclusion (Sie) systems act to block phage DNA injection into
E. coli [36], Lactococcus lactis [37], and Streptococcus thermophilus [38]. Similar systems have also been
recently discovered in Pseudomonas [39] and Mycobacterium prophages [40].
Prophages can also encode abortive infection (Abi) mechanisms that cause an interruption of
invasive phage development and a premature death of the infected bacteria. This leads to the release
of few or no progeny particles and thus prevents the expansion of the infection to the neighboring
bacteria [17,18]. Abi are very diverse; among those carried by prophages, some have been well
characterized such as the two component Rex system preventing lambda-lysogenic E. coli strain
infection by T4 phage [41] or the tyrosine kinase Stk of coliphage 933W that blocks the replication cycle
of HK97 [41,42].
Our earlier work showed that the vancomycin-resistant E. faecalis V583 clinical isolate hosts seven
prophage elements. One prophage is remnant and completely domesticated (prophage 2) while the
six others have various degrees of autonomy and different levels of interference with each other [43].
Only three of them—prophages 1, 3, and 5—are fully active and grow as plaques on a V583 derivative
cured of all six prophages. However, prophage 1 is parasitized during the induction of it lytic cycle by
the satellite prophage 7 also named a phage inducible chromosomal island. Prophages 4 and 6 finally
retain some phage-like behavior but no longer produce infective virions. They excise from the bacterial
chromosome in a process controlled by the other prophages, and once excised, prophage 4 replicates,
while prophage 6 cannot [43].
To investigate putative anti-phage roles played by V583 prophages, we performed a phage
screening using the V583 derivative strain cured of all plasmids and the six active prophages. We
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isolated a virulent phage belonging to the Picovirinae subfamily and to the P68 genus that contains
phages with small size genome (19–20 kb). This prompted us to name this phage Idefix, after the French
name of the small dog from Asterix comics. The genome sequence of two phages similar to Idefix have
been reported recently [13,44]. We showed that E. faecalis prophage 6, which apparently belongs to the
Siphoviridae family, is especially efficient in resisting to Idefix infection due to a new abortive infection
system that we call Abiα. This latter confers a typical Abi phenotype, by causing a premature lysis of
infected E. faecalis. The abiα gene is notably widespread among prophages integrated in enterococci
and other Gram-positive bacteria. Furthermore, the bacterium itself provides another line of defence
against Idefix through efficient mutagenesis of the phage bacterial receptor encoded within the variable
part of the epa locus responsible for the building up of the surface rhamnopolysaccharide of E. faecalis.
2. Materials and Methods
2.1. Sample for Bacteriophage Isolation, Bacterial Strains, Plasmids, and Growth Conditions
One raw sewage water sample from the Sèvres wastewater treatment plant (Paris area, France)
was used as a source of phage. E. faecalis indicator strain (cured of active prophages (strain
VE18590)) used for phage Idefix isolation, as well as strains and plasmids used for E. faecalis
phage-resistance characterization are listed in Table S1 (with supplementary references [45–50]).
Enterococcus strains tested to determine phage Idefix host range are detailed in Table S2 (with
supplementary references [51,52]). E. coli was cultivated at 37 ◦C in LB medium with shaking. L. lactis
was grown statically at 30 ◦C in M17 medium supplemented with glucose 0.5% (M17G). Enterococcus
strains were cultivated statically at 37 ◦C either in BHI medium or in M17G medium. Following
antibiotics were added when necessary: erythromycin, 10 µg·mL−1 for E. faecalis and 100 µg·mL−1
for L. lactis and E. coli strains; chloramphenicol, 20 µg·mL−1 and 10 µg·mL−1 for E. coli and E. faecalis
strains, respectively; kanamycin, 50 µg·mL−1 for E. coli strains.
2.2. Phage Isolation
Phage Idefix was isolated using the standard double overlay plaque assay technique as previously
described [44] with minor modifications. A standard Petri dish was filled with 20–30 mL of BHI
medium containing agar 1.5% and MgSO4 10 mM. One hundred microliters of 0.45 µm filtered sewage
was mixed with 500 µL of an overnight culture of the indicator strain, then added to 5 mL of BHI
medium containing agarose 0.4% and MgSO4 10 mM, and poured onto the bottom agar. The double
agar/agarose plate was incubated 24 h at 37 ◦C and screened for plaque appearance. Many different
plaques were obtained, and among them, a large clear plaque was picked and streaked on an agar base
before applying the second layer of BHI top agarose mixed with the overnight culture of the indicator
strain. The plate was incubated 24 h at 37 ◦C and a large clear plaque was streaked again twice, to
ensure phage purity.
2.3. Phage Concentration and Purification
Starting from a large clear plaque, virions were resuspended in 1 mL of SM buffer (Tris-HCl
10 mM pH 7.5, MgSO4 10 mM, NaCl 300 mM) and the suspension was centrifuged 10 min at 7500× g
and room temperature. Phage titer in the supernatant was determined by preparing serial dilutions in
SM buffer and using the double overlay method. High-titer phage stock was obtained as previously
described [53] with slight modifications. Five hundred to one thousand phages were plated using the
double overlay method, which led to a confluent lysis after 12 h at 37 ◦C. The plate was then flooded
with 5 mL of SM buffer and incubated 2 h at 4 ◦C. The overlay was carefully collected and centrifuged
20 min at 7500× g at room temperature and the phages-containing supernatant was passed through a
0.45 µm filter. Phage stocks were titrated (~1011 PFU·mL−1) and stored at 4 ◦C for further experiments.
Ten milliliters of filtered phage stock was incubated 12 h at 4 ◦C under stirring in the presence of NaCl
1M and PEG 8000 10%. Precipitated phages were then centrifuged 20 min at 10,000× g and 4 ◦C and
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slowly resuspended in 1 mL of SM buffer for 1 h at 4 ◦C prior to be purified by centrifugation in a CsCl
buoyant gradient. The purified phage-containing fraction was then recovered (density 1.4), titrated
and stored at 4 ◦C for further experiments.
2.4. Phage Examination in Transmission Electron Microscopy
Ten microliters of purified phage Idefix fraction were directly spotted onto a Formwar carbon
coated copper grid. Phages were allowed to adsorb to the carbon layer for 5 min and excess of liquid
was removed. Ten microliters of a staining uranyl acetate solution (1%) was then spotted to the grid
for 10 s and excess of liquid was removed again. The grid was imaged at 80 kV in a Hitachi HT7700
transmission electron microscope.
2.5. Phage Genomic Nucleic Acid Extraction, Whole Genome Sequencing, and Bioinformatic Analysis
Total DNA was extracted as described in [54,55]. Prior to DNA extraction, 10 mL of the phage
stock (1011 PFU·mL−1) was treated with 40 µL of nuclease mix (50% glycerol, 0.25 mg·mL−1 RNAse
A, 0.25 mg·mL−1 Dnase I, 150 mM NaCl), for 15 min at 37 ◦C. Particles were then precipitated by
adding PEG 8000 (10%, w/v) and NaCl to 1 M, and let sit overnight at 4 ◦C once PEG was solubilized.
Phages were centrifuged 10 min at 10,000× g and room temperature, and resuspended into 500 µL of
SM buffer. Insoluble particles were removed by centrifugation (20 s at 12,000× g), and the clarified
supernatant was used for DNA extraction. The PROMEGA Wizard DNA Clean up kit (ref A7280)
was then used, following essentially the manufacturer instructions. Prior to DNA elution from the
column, a washing step with 5.4 M guanidium thiocyanate (resin solution) was applied. DNA was
sent to a 454-sequencing platform, and reads were assembled with Newbler [56]. The phage genome
was annotated using RAST [57], followed by manual inspection. The genome sequence is available
under the accession number LT630001.1. All genomic figures, including Idefix genome comparison,
were generated using Easyfig [58].
2.6. Determination of Phage Burst Size
The one-step growth kinetic curve of phage Idefix was measured using a standard method [59]
with minor modifications. One milliliter of a log-phase culture of indicator strain was centrifuged
5 min at 10,000× g and room temperature, and resuspended in 100 µL of prewarmed BHI medium
with MgSO4 (10 mM). Phage from the high-titer phage stock was added at a MOI of 0.001 and allowed
to adsorb for 5 min at 37 ◦C. The phage/bacteria mix was centrifuged 2 min at 10,000× g and room
temperature. The supernatant was titrated to count unadsorbed phage particles, whereas the bacterial
pellet was washed in 100 µL of prewarmed BHI medium with MgSO4 (10 mM) and recentrifuged.
The pellet was suspended and diluted in 10 mL of prewarmed BHI medium with MgSO4 (10 mM)
and cultured at 37 ◦C. Samples were taken at regular intervals and plated at the correct dilution for
phage titration. A second set of samples from a synchronized 100-fold diluted culture was taken
at same intervals and titrated. The values indicate the means and standard deviations of three
independent experiments.
2.7. Determination of Phage Host Range
Ten microliters of serially diluted high-titer phage stock were spotted (10 µL) on top of agarose
overlays containing overnight culture of enterococci, as described above (Table S2). Plates were
incubated at 37 ◦C and examined for plaque appearance 6, 12, and 24 h after spotting.
2.8. Determination of Phage Efficiency of Plaquing
Efficiency of plaquing (EOP) was determined for E. faecalis derivative strains (Table S1). One
hundred phages were plated using the double overlay plaque assay technique. EOP were calculated
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as ((phage titer on tested strain) × (phage titer on the indicator strain)−1) × 100. These experiments
were independently performed three times and average values are reported with standard deviations.
2.9. Phage Adsorption Assay
Adsorption of phage to E. faecalis derivative strains were determined as reported previously [60]
with minor modifications. One milliliter of log-phase cultures was harvested and resuspended in
100 µL of BHI medium with MgSO4 (10 mM), and then phage from the high-titer phage stock was
added at a MOI of 0.001. Following incubation for 10 min at 37 ◦C, the phage/bacteria mixtures were
centrifuged 2 min at 10,000× g and room temperature. Supernatants were plated at the correct dilution
and titrated for phage. Percentages of adsorption were calculated as ((control titer - residual titer) ×
(control titer)−1) × 100. These experiments were independently conducted three times and average
values are given with standard deviations.
2.10. Determination of Phage Efficiency of Center of Infection
Efficiency of center of infection (ECOI) was determined for E. faecalis derivative strains as detailed
by [61] with minor modifications. One milliliter of log-phase cultures was harvested and resuspended
as previously, and then phage from the high-titer phage stock was added at a MOI of 0.001. Following
incubation for 5 min at 37 ◦C, the phage/bacteria mixtures were centrifuged 1 min at 10,000× g and
4 ◦C, washed twice, diluted, and assayed for infective centers. An E. faecalis strain which does not
adsorb Idefix was used as control to monitor the effectiveness of phage removal during washing.
Percentages of ECOI were calculated as ((number of centers on indicator strain) × (number of centers
on tested strain)−1) × 100. These experiments were independently performed three times and average
values are reported with standard deviations.
2.11. Bacterial Survival Assay
E. faecalis derivative strains survival was assayed as essentially described in [62] with slight
modifications. Briefly, one milliliter of log-phase bacterial cultures was harvested and resuspended
as previously described, and then phage from the high-titer phage stock was added at both MOI of
1 and 10. Following incubation for 20 min at 37 ◦C, bacterial suspensions were plated at the correct
dilution on agar plates and surviving bacteria were enumerated as CFU. Percentages of bacterial death
were calculated as ((CFU·mL−1 in cultures without phage − CFU·mL−1 in cultures with phage) ×
(CFU·mL−1 in cultures without phage)−1) × 100. These experiments were independently conducted
three times and average values are shown with standard deviations.
2.12. Lysis Curve Experiments
One milliliter of log-phase bacterial cultures was harvested and resuspended as previously
described, and then phage from the high-titer phage stock was added at an MOI of 10. Following
incubation for 10 min at 37 ◦C, the phage/bacteria mixtures were centrifuged 2 min at 10,000× g and
room temperature. Pellets were resuspended in 200 µL of BHI medium with MgSO4 (10 mM) and the
suspensions were transferred in wells of a 96-wells plate. Empty wells are filled with BHI medium or
uninfected bacterial suspensions to have negative and positive growth control respectively. Bacterial
growths were then monitored during 30–50 min at 37 ◦C using a Tecan plate reader (OD 600 nm,
measurements at 2 min intervals after shakings). During the experiment, each sample was prepared
and monitored in triplicates. Kinetics shown are representative of three independent experiments.
2.13. Luria–Delbrück Fluctuation Tests
An exponentially growing E. faecalis strain cured of prophage 6 (strain VE18306) culture
supplemented with 10 mM MgSO4 was distributed in a 96-wells plate (180 µL, corresponding to
~2 × 104 CFU, in 93 wells), and infected with phage Idefix (20 µL, corresponding to ~2 × 109 PFU,
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which are dispensed before bacteria, in 90 of the 96 wells). Remaining wells contained either BHI
medium or uninfected VE18306 cultures. Following static incubation of the plates for 12 h at 37 ◦C,
bacterial growth was evaluated using a Tecan plate reader, after a 1 min shaking step (OD 600 nm).
If mutations occur at random in the bacterial population, the number of mutational events per well
follows a Poisson distribution [63], and the proportion of wells in which no mutant resisting to Idefix
was present at the time of infection P0, is related to h, the expectation of this law, by the formula P0 =
e−h. Knowing the average number of bacteria per well at infection, N, mutation frequency f = h/N, so
f = −lnP0/N. These experiments were independently performed three times giving a similar value of f.
2.14. General Molecular Biology Methods
All PCR reactions to clone or sequence IDF_13, IDF_15, ef2833, ef2847, ef2850, ef2169, and ef2170
genes were performed in a Mastercycler Eppendorf with Phusion high-fidelity DNA polymerase (NEB)
and according to manufacturer’s instructions. PCR products and DNA restriction fragments were
purified with QIAquick kits (QIAGEN, Hilden, Germany) when necessary. Electro-transformation
of E. coli, L. lactis, and E. faecalis were carried out as previously described [64,65] using a Gene Pulser
apparatus (Bio-Rad Laboratories, Inc., Hercules, CA, USA). Transformations of chemically competent
E. coli ER2566 were carried out by a heat shock procedure.
2.15. Cloning of IDF_13 and IDF_15, Expression and Preparation of Extracts of E. coli, and Spot Assay of the
Extracts on the Indicator Strain
PCR amplification of IDF_13 and IDF_15 were performed using primer pairs OFL264/OFL265
and OFL266/267 respectively, with Idefix genomic DNA as template. PCR products were purified
and digested by NdeI and BamHI restriction enzymes. Digested products were purified and cloned
between the NdeI and BamHI sites of a linearized pJ411 derivative (Table S1). JM105 transformants
were selected on LB plates supplemented with kanamycin. The resulting plasmids, pAB1and pAB2,
contained the corresponding ORF fused in 5’ to a sequence coding for a His6-tag, placed under the
control of a T7 promoter. His6-tagged IDF_13 and IDF_15 were produced in E. coli ER2566 transformed
with pAB1 and pAB2 respectively. Cells were grown in 50 mL of LB supplemented with kanamycin at
37 ◦C. At OD600 = 0.6, production of the phage proteins was induced by addition of IPTG (0.5 mM
final concentration) to the culture for 2.5 h. Cells were then harvested by centrifugation at 5200×
g for 7 min at 4 ◦C and resuspended in 1 mL of lysis buffer (Tris-HCl 50 mM pH 8, NaCl 150 mM).
Cells suspensions were stored at −20 ◦C until preparation of crude extracts. After thawing, bacteria
were lyzed by sonication on ice. The lysates were centrifuged at 4 ◦C for 20 min at 20,000× g and the
supernatants were stored at −20 ◦C. Production and solubility of IDF_13 and IDF_15 were verified by
SDS-PAGE. Lysis activity of IDF_13 and IDF_15 was assessed by spotting 5 µL of the supernatants
alone or a mix of both fractions on an indicator strain bacterial lawn as previously described.
2.16. Construction of E. faecalis VE18306 ef2833-, ef2847- and ef2850-Complemented Strains and E. faecalis
VE18590 ef2833- Complemented Strain
Complementations of the prophage 6 genes ef2833, ef2847, and ef2850 were done using the
pJIM2246 vector (Table S1). The three genes were amplified including their constitutive promoters
and ribosome binding sites from DNA of E. faecalis strain containing all prophages (strain VE14089)
with primer pairs JL12/JL13, JL10/JL11, and JL8/JL9 respectively (Table S1). The three purified
products were separately cloned into pJIM2246 yielding plasmids pJL1, pJL2, and pJL3 after respective
transformation into E. coli JM105 and chloramphenicol selection. pJL1, pJL2, and pJL3 were then
separately electroporated into E. faecalis cured of prophage 6 (strain VE18306). The ef2833-, ef2847-,
and ef2850-complemented strains were respectively selected on chloramphenicol. The nucleotide
sequences of cloned PCR products were systematically confirmed by sequencing using primer pairs
OEF879/1233 (Table S1). pJL3 and pJIM2246 were also separately electroporated into the indicator
strain and selected as previously described.
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2.17. PCR Amplification in epaX Region
epaX region was amplified from total DNA of nine Idefix spontaneous resisting mutants using
primer pairs OEF394/OEF397 and OEF527/OEF397 (Table S1). PCR analysis was extended for the
three mutants for which no IS insertion was discovered with larger amplifications downstream and
upstream epaX region using primer pairs OEF857/OEF527 and OEF885/OEF858; and OEF528/OEF856
and OEF859/OEF823 (Table S1) respectively.
2.18. Construction of E. faecalis VE18306∆epaX Strain
A deletion of epaX in the VE18306 background was constructed by double homologous
recombination using pVE14283 plasmid (Table S1). pVE14283 was electroporated into strain VE18306,
and the epaX deletion (strain VE18393, Table S1) was selected as described in [49,66].
2.19. Construction of E. faecalis VE18393 epaX—Complemented Strain
A complementation of epaX was constructed using pVE14297 plasmid (Table S1). This latter,
containing epaX under the control of the constitutive promoter PaphA3, was electroporated into the
VE18306 ∆epaX strain (strain VE18393) and the complementation (strain VE18945, Table S1) was
selected as described in [49]. A control strain, harboring pVE14176 vector devoid of epaX, was also
obtained (strain VE18944, Table S1).
3. Results
3.1. Characterization of the Enterococcus Phage Idefix
3.1.1. Isolation, Morphological Characterization, and Phage–Host Relationship
One municipal sewage water sample from Sèvres (Paris area, Ile de France region) was screened
by direct plating without enrichment for phages forming plaques on the indicator strain. This latter,
VE18590 (here below pp−, complete names of all strains used are listed in Table S1), corresponds to
an E. faecalis V583 derivative deleted from its endogenous plasmids and six active prophages [43]. A
phage making particularly large and clear plaques was isolated with the double-layer technique. After
purification and amplification, transmission electron microscopy revealed a virion with an icosahedral
head ~40 nm in diameter and a very short non-contractile tail (Figure 1A). This phage, Idefix, therefore
belongs to the Caudovirales order and the Podoviridae family. A one-step growth kinetic indicated that
Idefix has a latent period of 15 min and a burst size ~50 PFUs per infected pp− bacterium (Figure 1B).
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3.1.2. Genomic Characterization
The genome of phage Idefix is a double stranded linear DNA, consisting of 18,168 bp with
inverted terminal repeats 61 bp long and an average GC content of 33.2%. It is highly homologous to
Enterococcus phages vB_EfaP_IME195 (95% coverage and 92% nt identity) and vB_Efae230P-4 (75%
coverage and 85% identity) (Figure 2). These genomes belong to virulent podophages, which were
isolated from sewage samples in China and Poland, respectively [13,44]. A close relative phage,
vB_EfaP_IME199, infecting an E. faecium strain has also been described [14]. Genbank accession
numbers of these genomes are listed in Table S3.Viruses 2019, 11 9 
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from vB_Efae230P-4, vB_EfaP_IME195, and Idefix compared to Streptococcus phage C1, Staphylococcus
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The Idefix genome encodes 25 ORFs, 12 of which were assigned a function (Figure 2 and Table
S4). The replication module contains a single strand DNA binding protein (SSB, IDF_02) and a DNA
polymerase belo ging to the B type superfamily (Pol, IDF_07). This polymerase presents all the
conserved motifs typ cal of phage phi29 p lymeras , including the specific regions of the “protein
priming” subfamily [67–71] (Figure S1).We next s arched for the gene coding the term al protein used
to initiate the replication at both ends of Picovirinae linear genomes. Such genes are generally located
near the polymerase gene but very poorly conserved. Terminal proteins share features like a small
size and a high isoelectric point [72,73]. Based on these criteria, IDF_05 appears the best candidate
(Table S4) but additional investigations are needed to confirm this hypothesis. A gene encoding an
encapsidation protein (IDF_06) separates this putative terminal gene and the polymerase gene. The
lysis module is composed of a holin (Hol, IDF_16) and two different putative endolysins (Lys): IDF_15
and IDF_13. IDF_15 displays homology with N-acetylmuramoyl-L-alanine amidases (Figure S2A,B). To
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test whether this gene expresses an active endolysin, IDF_15 was cloned in an expression vector based
on a T7 promoter (plasmid pAB2) and expressed in E. coli ER2566 (Figure S4A). Spotting of a soluble
cell extract (containing IDF_15, Figure S4A) on a pp- bacterial lawn revealed a lysis zone (Figure
S4B). This result tends to show that IDF_15 has an endolysin activity. IDF_13 displays homology with
PlyCA [74–76], a subunit of the PlyC endolysin synthetized by the Streptococcus podophage C1 (Figure
S3A). Indeed IDF_13, like plyCA, encodes a protein with two catalytic domains. A putative glycosidase
domain (homologous to the one of PlyCA) and a putative “CHAP” domain (more divergent compared
with the one found in PlyCA) are respectively located in the N and the C terminus of the protein
(Figure S3B,C). In contrast to IDF_15, a soluble cell extract of an E. coli strain expressing the IDF_13 (via
plasmid pAB1) did not lead to a bacterial lysis (Figure S4A,B). Moreover, a mix of extracts containing
IDF_13 and IDF_15 did not produce increased lysis (Figure S4B). C1 is the only reported phage whose
endolysin PlyC is synthesized from two genes: plyCA and plyCB. To form the complete enzyme, the
catalytic subunit PlyCA and eight subunits PlyCB harboring the cell wall binding domain (CBD)
are associated [75,77]. However, we were not able to find an Idefix ORF displaying any significant
similarity with PlyCB. We concluded that IDF_15 seems to encode a canonical monomeric endolysin,
and that more experiments are required to determine whether IDF_13 is just remnant of a former
endolysin module, or retains activity combined with another Idefix protein to form a multimeric
endolysin. Finally, the structural module includes genes encoding a tail protein (IDF_17), connector
proteins (IDF_20 and IDF_21) and a major head protein (MHP, IDF_22) (Table S4).
Comparative genomic analyses clearly show that Idefix and the other homologous Enterococcus
phages belong to the Picovirinae subfamily [78] composed of small virulent podophages infecting
Gram-positive bacteria and encoding a phi29-like DNA polymerase. The Picovirinae subfamily is
subdivided into P68, phi29, Cp-1 genera and one unassigned genus (Figure 2). The overall synteny
and the MHP similarities [14] both lead to assign Idefix and all other Enterococcus Picovirinae to the P68
genus, including one Streptococcus and some Staphylococcus phages (Figure 2). Within this genus, a
hallmark of all Enterococcus phages is the presence of two genes coding putative endolysins (IDF_13
and IDF_15 in Idefix).
3.1.3. Phage Host Range
Plaque assays of Idefix were performed on fifty-nine Enterococcus strains, belonging to the E.
faecalis (47) and to the E. faecium (12) species. E. faecalis strains had sewage, clinical, commensal, or
food origins and represented a range of different clonal complexes and capsule types, whereas faecium
strains essentially belonged to different sequence types from the most prevalent clinical clonal complex
(Table S2). Idefix did not propagate on any of them, including the wild type strain V583 (wt), from
which our indicator sensitive strain pp− is derived (Figure 3A,B).
3.2. Characterization of E. faecalis V583 Resistance to Idefix
3.2.1. Novel Abi System Encoded by V583 Prophage 6
To investigate the mechanism by which E. faecalis V583 resists Idefix infection, we made use
of our collection of V583 derivatives deleted for either plasmids or prophages [43]. The plasmids
hosted by V583 were not responsible for the resistance to Idefix, as the use of the plasmidless V583
derivative strain VE14089 (pp+, Table S1), did not permit Idefix growth (Figure 3C). Plaque assays
were next performed on V583 plasmidless derivatives where only one of the prophages remains.
Idefix grew on all derivatives (Figure 3D–H) but one, VE18581 (pp6+) in which prophage 6 is present
(Figure 3I). We concluded that prophage 6 is necessary to confer resistance to Idefix. Plaque assays
on the V583 derivative VE18306 (pp6−) in which only prophage 6 is deleted, led to clear plaque
appearance (Figure 3J) with efficiency of plaquing (EOP) similar to pp− (Table 1). We concluded that
prophage 6, which structural genes are notably related to the siphophage HK97, is sufficient for Idefix
resistance. Interestingly, we noticed that plaque size was reduced (~three times smaller) whenever
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prophage 3 was present (Figure 3G,H,J) (Table 1), suggesting that prophage 3 slightly interferes during
Idefix infection.Viruses 2019, 11 10 
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plasmids and prophages. C. pp+ (VE14089), a V583 derivative only deleted from all its plasmids. D.
pp4+ (VE18582), a VE14089 derivative deleted for all its pps but pp4. E. pp7+ (VE18589), a VE14089
derivative deleted for all its pps but pp7. F. pp1+ (VE18562), a VE14089 derivative deleted for all its pps
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(VE18584), a VE14089 derivative deleted for all its pps but 3. I. pp6+ (VE18581), a VE14089 derivative
deleted for all its pps but pp6. J. p6− (VE18306), a VE14089 derivative only deleted from pp6.
Table 1. Efficiency of plaquing (EOP) of phage Idefix on E. faecalis V583 derivatives deleted from
different prophages.
Strain (Genotype) Average EOP of Idefix (sd) Plaque (Diameter)
VE18590 (pp−) 1 Big clear plaque (3–4 mm)
VE18562 (pp1+) 1.1 (0.17) Big clear plaque (3–4 mm)
VE18582 (pp4+) 0.92 (0.14) Big clear plaque (3–4 mm)
VE18589 (pp7+) 1.03 (0.16) Big clear plaque (3–4 mm)
VE18583 (pp +, pp5+) 0.97 (0.16) Reduction in size (1 mm)
VE18584 (pp3+) 0.92 (0.17) Reduction in size (1 mm)
VE18581 (pp6+) 0 * No plaque visible
VE18306 (pp6−) 1 (0.13) Reduction in size (1 mm)
* Below the detectable limit of the assay, at least < 1.2 × 10−8.
To characterize the resistance conferred by prophage 6, adsorption assays were first performed on
a panel of strains differing for the presence or absence of this propha . Idefix adsorption was always
efficient, regardless of the presence of prophage 6 (Table 2), showing therefore that prophage 6 does
not prevent Idefix adsorption. We next assayed efficiency of center of infection (ECOI) by Idefix on the
same panel of strains, which can detect infective events, regardless of phage burst size. It was reduced
to 39% upon infection of strain pp6+. This reduction was even more drastic when the strain pp+,
carrying all prophages, was tested, with only 15% of the infections leading to phage production. This
suggests again that some other prophage gene(s) impede Idefix growth. However, infection of strain
pp6− permitted to recover plaques for nearly 70% of all infecting particles, suggesting that prophage
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6 contribution to interference is major (Table 2). We finally tested whether prophage 6 affected cell
survival upon Idefix infection. Cell survival following exposure to Idefix was similar irrespective of the
presence of prophage 6: even in the Idefix resistant strains, percentage of cell death was around 50–70%
at MOI of 1, and around 100% at MOI of 10, like in Idefix sensitive strains (Table 2). We concluded
that prophage 6 encodes a typical Abi mechanism affecting the production of virions while leading
simultaneously to host cell death upon Idefix infection.
Table 2. Parameters of phage Idefix proliferation on E. faecalis strains differing by the presence or
absence of prophage 6 or prophage 6-encoded ef2833.
Strain
(Genotype)
% EOP (Plaques
Diameter) % Adsorption (sd) % ECOI (sd)
% Bacterial Death at
MOI 1 (sd) and MOI
10 (sd)
Indicator strain
VE18590 (pp−) 100 (3–4 mm) 96.5 (1.63) 100 69.0 (0.39) and 99.2 (0.78)
VE18306 (pp6−) 100 (1 mm) 97.1 (1.35) 69.3 (3.10) 52.8 (3.00) and 98.2 (0.98)
VE18581 (pp6+) 0 None plaques visible 97.5 (0.92) 39.5 (3.94) 66.8 (2.78) and 98.2 (1.32)
VE14089 (pp+) 0 None plaques visible 98.1 (2.36) 15.9 (4.01) 60.2 (3.46) and 98.9 (0.19)
VEJL3 (pp6−, ef2833+) 0 None plaques visible 98.4 (0.68) 9.46 (2.68) 67.7 (1.65) and 98.6 (0.46)
VEJL5 (pp−, ef2833+) 0 None plaques visible 98.5 (1.33) 13.8 (0.58) 63.2 (1.98) and 96.6 (1.36)
To search for prophage 6 candidate genes involved in this Abi mechanism, we analyzed
transcriptomic data of strain pp+ [48]. Eight of the prophage 6 encoded genes are expressed
constitutively during normal growth conditions, in contrast to the generally low expression level of the
remaining 50 genes carried by the prophage (Figure 4A). Two of these genes, ef2855 and ef2852, encode
the integrase and repressor proteins, which are implicated in the lysogenic control of the prophage.
Between these two genes, and probably forming an operon with them, genes ef2854 and ef2853 encode a
putative membrane protein and a putative metallo-peptidase, respectively. A similar gene pair, placed
between an integrase and a repressor, is found in several Sie prophage-encoded phage resistance
systems within the Lactococcus genus [37,79]. These systems block the phage DNA injection step, due
to the membrane protein. The nearby metallo-peptidase is dispensable, but sometimes enhances the
resistance efficiency [37,79]. Given that Sie systems do not affect bacterial survival, we did not consider
the gene pair ef2853 and ef2854 as responsible for the observed resistance to Idefix infection. Among
the four last candidate genes, ef2801 is disrupted by a transposable element invalidating a putative
glycosyltransferase, so that our investigation was restricted to the three remaining genes ef2833, ef2847,
and ef2850.
All of them are preceded by a promoter region including an experimentally mapped
transcription-starting site [80] and encode proteins with unknown function. We thus cloned these
three genes individually with their own promoters on pJIM2246 vector (Table S1), and performed
Idefix infections in pp6− transformed by each of the plasmids. Plaque assays revealed that Idefix was
able to infect all strains (Figure 4B(a,b) but the one hosting plasmid pJL3, in which ef2833 is expressed
(Figure 4B(c)). We additionally tested plasmid pJL3 in the pp− background and found that this strain
was also resistant to Idefix (Figure 4B(d)) whereas the phage grew on the isogenic strain hosting the
empty vector (Figure 4B(e)) as well as on pp− (Figure 4B(f)).
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resistance. (A) Genomic organization of pp6 and relative transcription level of each gene. The genomic
organization of pp6 is modified from [43]. Gene functions are color-coded and detailed wherever
possible (red: integrase, yellow: transcriptional regulation, orange: DNA metabolism, green: DNA
packaging and head, light blue: head to tail, dark blue: tail, fuchsia: lysis, grey: hypothetical proteins,
white: transposable element). Relative transcriptional level of each gene is indicated in black and
designed from a previously published transcriptomic study [48]. Eight pp6 genes are constitutively
expressed during V583 normal growth conditions. Among those not involved in pp6 lysogenic decision:
a membrane protein d putative metallo-peptidase genes ar indicate with triangles, a putative
glycosyltransferase gene disrupted by a transposable element is indicated with a cross and the three
other g nes tested as abi candidates are indicated with re st r . (B) Interferenc with Idefix infection
following the expression of the three pp6 abi candidates, plaque assays performed on strain pp6− (A to
C) or pp− (D to F) transformed by: a. pJL1. b. pJL2. c. pJL3. d. pJL3. e. the pJIM2246 empty vector. f.
no vector.
We then checked the other proliferation parameters of Idefix on the two strains hosting the pJL3
plasmid. The phage adsorbed as efficiently on these strains, its ECOI was reduced to ~10% and the
percentage of cell death were around 60–70% at MOI 1 and around 100% at MOI 10 in both cases
(Table 2). These results confirmed that ef2833 is responsible for the abortive mechanism. As letters from
abiA to abiZ have been used once to designate over 20 L. lactis Abi systems [18,81], we renamed ef2833
as “abiα”. The corresponding encoded protein contains 272 residues, and does not exhibit similarity
with any domain or protein of known function. Abiα nevertheless constitutes a PFAM domain referred
to as DUF4393 (158 sequences, 140 species, both Gram+ and Gram−), suggesting already its broad
distribution (see below). Abiα also shares similarity with Pfam entry PF10987 and PDB entry 3H35
without providing any substantial information about Abiα function.
To characterize the Abiαmode of action, lysis curves were conducted and indicated that strain
pp− containing plasmid pJL3 lyses ~10 min earlier than its isogenic strain devoid of abiα after infection
Viruses 2019, 11, 48 13 of 22
by Idefix (MOI 10) (Figure 5A). The same results were obtained when comparing lysis curves of the
prophage positive and prophageless strains pp6+ and pp−, respectively (Figure 5B). We concluded
that Abiα provokes a lysis asynchrony.
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To evaluate the prevalence of abiα and its genetic context, the protein sequence was searched in
the JGI database with the IMG interface ([82]; BLASTP, E-value < 3.10−8, Identity ≥ 25%). Homologs
of Abiα were found mostly on prophages, with some of them shown in Figure S6: the closer relatives
(61–59% sequence identity) came from various enterococci, such as E. faecium and Enterococcus villorum
isolates, and subsequent nalyses with the NCBI nt database also reveale a homolog in an Enterococcus
hirae prophage (not shown i Figure S6). Other Abiα were found in about 50 Lactob cillus strains
(27–42% sequence identity). Roughly, half of t ese genes are encoded on pr phages (as in L. johnsonii,
L. salivarius or L. plantarum isolates) whereas the other half are located on the chromosomes (as in
L. lindneri and L. helveticus isolates). Interestingly, in L. helveticus, and in two Oenococcus species
(O. kitaharae and O. oeni), the abiα gene is close to other putative Abi systems, and may belong to a
phage resistance island. Sporadic occurrences (31–37% sequence identity) were also found in three
Streptococcus species (S. suis, S. bovis, and S. parasanguinis), and one Carnobacterium isolate. A prophage
context was detectable in this latter and in S. parasanguinis. Additional prophage-encoded genes with
25–27% sequence identity with abiα were located in one Lactococcus lactis ssp. lactis (not shown in
Figure S6), Bacillus velezensis, Staphylococcus epidermidis, Staphylococcus scuiri and Staphylococcus aureus.
We conclude that Abiα is widely distributed, and hypothesize it has a phage origin.
3.2.2. Mutagenesis in V583 epa Variable Region as Potential Additional Line of Defense
During this work, we regularly observed phage-resistant colonies growing within lysis zones of
the pp6− strain. Fluctuation tests of Luria-Delbrück allowed estimating that the frequency of mutations
resulting in resistance of the strain was 1.56 (± 0.54) × 10−4 per cellular division. We conclude that
spontaneous resistance to Idefix arises at high frequency in E. faecalis strain devoid of abiα.
To gain further insights into the bacterial mechanisms of resistance to Idefix, we tested nine
spontaneous Idefix resistant mutants randomly isolated from fluctuation tests. Idefix adsorption
was reduced for all mutants: three of them had a 2-to-4-fold reduced adsorption efficiency and the
remaining six, rather a 10-fold defect (Table S5). We conclude that bacterial resistance to Idefix is due
to an adsorption defect.
More than 10 years ago, a study of the podophage C1 distantly related to Idefix (see Figure 2)
had proposed that the N-acetylgalactosamine (GalNac) composing the side chains of the group C
streptococci surface rhamnopolysaccharide should be a crucial element of the bacterial receptor [83].
Enterococci, like group C streptococci, harbor a surface rhamnopolysaccharide or Epa (Enterococcal
polysaccharide antigen), which is synthesized by more than thirty proteins encoded within a single
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cluster of genes. The upstream part of this gene cluster is shared among E. faecalis strains, while the
immediately downstream region is variable between strains [84]. Within this epa variable region, epaX
encodes a glycosyltransferase involved in the incorporation of galactose and/or GalNac proposed to
form the side chains of the rhamnopolysaccharide in E. faecalis [49]. We therefore started by examining
the epaX region in the nine mutants. PCR amplification of epaX led to a DNA product of increased
size in six out of nine mutants (~4000 instead of ~2500 bp). Sequencing revealed that epaX gene was
disrupted by an IS256 insertion sequence, positioned in either direction, and at six different locations,
all of them in the very distal 3’ region of epaX (Figure 6 and Table S5).
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We next reconstructed a deletion of epaX in the pp6− background. Again, Idefix was almost
unable to adsorb to the resulting strain (VE18393, Table S1) with only 5% (± 8) of adsorption, nor to lyse
it (Figure 7A). Complementation of this epaX mutant with plasmid pVE14176 expressing constitutively
epaX under a strong promoter (strain VE18945, Table S1) restored Idefix adsorption, which reached 96%
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To characterize the three remaining Idefix-resistant mutants, in which no IS was detected in the
epaX region by PCR, we sequenced the genome of one of them, and mapped the reads against the pp6−
reference genome. We identified a 33 nt-long deletion, flanked by 11 nt-long direct repeats, within
ORF ef2169 encoding a predicted O antige polymerase, and located immediately d wnstream of epaX.
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PCR amplification and sequencing of ef2169 gene in the two last mutants allowed to detect the same
33 nt deletion in both of them (Figure 6 and Table S5). The observed deletion results in an in-frame
11 amino acids deletion in the C-terminal region of the putative O antigen polymerase. Additional
single nucleotide polymorphisms (introducing amino acid substitution and a premature stop codon,
respectively) were also observed in these two last ef2169 mutants (Table S5). Complementation of the
ef2169 mutation could not be checked, due to our failure to clone the ef2169 gene on a plasmid, despite
repeated attempts in E coli, L. lactis, and E. faecalis.
4. Discussion
Enterococci are particularly successful at rapidly acquiring resistance to virtually any antibiotic
used in therapy, with vancomycin-resistant enterococci (VRE) being a major clinical problem. If phage
therapy is consequently nowadays (re)considered as an alternative to combat VRE infections, we
are still nowhere near using enterococci phages as therapeutic agents in routine. Before that, we
need to better characterize (i) enterococci phage receptors that define phage strain specificity, and (ii)
enterococci resistance mechanisms that constitute the major constraint of phage therapy [7,16].
The present study with the new virulent podophage, Idefix, fulfills these goals. The phage was
isolated by using the reference vancomycin-resistant E. faecalis V583 clinical isolate, deleted from
its endogenous plasmids and prophages, as a recipient for phage infections. Idefix belongs to the
Picovirinae subfamily and P68 genus and is closely related to three phages recently isolated on E.
faecalis [13,44] or E. faecium [14]. They encode a DNA polymerase from the B type superfamily, which
is a hallmark of the Picovirinae. As an additional hallmark of these enterococci podophages, they
all encode two types of predicted endolysins. Endolysin engineering has emerged as a suitable
strategy for food safety, environment decontamination, and infections control [85]. Some of the
characterized enterococci phage endolysins show potential to combat VRE in vivo [15,86] and could
represent an alternative to resolve the VRE problem. Idefix both encodes endolysin IDF_15, a predicted
N-acetylmuramoyl-L-alanine amidase for which we could presume activity by spot assays on bacterial
lawns, and IDF_13, similar to the catalytic subunit of the endolysin PlyC encoded by Streptococcus
phage C1, which was inactive in the same spot assay. PlyC is the unique example of multimeric
endolysin and represents the more active peptidoglycan hydrolase reported to date [85]. We were
unable to identify by similarity an Idefix gene that could encode the CBD of this complex, and allow
the formation of a putative multimeric endolysin. CBD of endolysins bind to specific substrates on
the bacterial surfaces, often giving rise to near-species-specific binding, so that endolysins of the
same class often share very little sequence similarity in the binding region [85]. Identification of the
CBD subunit homolog in Idefix and complete characterization of this intriguing endolysin requires
further investigation.
Idefix was unable to lyse any of our fifty-nine strains of E. faecalis and E. faecium, suggesting it
could originate from another enterococcal species. Plaques were obtained against the indicator strain
used for its isolation, and not on the wild type isolate V583 from which the indicator strain is derived.
This apparently narrow host range could be explained by the reported Abiα-sensitivity and perhaps
more importantly by the receptor-specificity of Idefix.
In V583, resistance to the phage was mainly due to the gene abiα (formerly ef2833) encoded by
prophage 6. Upon Idefix infection, cells are dying while the Idefix lytic cycle is perturbed (ECOI
of ~40% and ~10% whenever abiα is expressed on prophage 6 or overexpressed on cloning vectors,
respectively) so that its efficiency of plaquing is below 10−8 and the detectable limits of the assay
for Idefix. To our knowledge, it is the first time that an Abi system is described within enterococci,
and the first one targeting a Picovirinae. This new Abi protein is widely distributed, it corresponds
to the PFAM DUF 4393, and we report here that it is mostly found in prophages, arguing that it is
essentially a temperate phage weapon to fight against other phages. Abi are specific anti-phage defence
mechanisms present in many bacterial species including Shigella dysenteriae, Streptococcus pyogenes,
Vibrio cholerae, Bacillus subtilis, and Bacillus licheniformis [62,87–90]. They have been more extensively
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studied in L. lactis and E. coli [17,81]. Most abi genes are encoded by a single gene on mobile genetic
elements (MGE), on prophages in E. coli [91], or plasmids in L. lactis [81]. The fact that most abi genes
are plasmidic in L. lactis may result however from a bias of human selection for plasmid-encoded
systems in the dairy industry. Abi actually include a large collection of diverse mechanisms acting at
any stage of the phage development to decrease or completely block virion production and cause host
cell death. All these mechanisms display little or no known evolutionary relationship, apart from a
very similar phenotype [18,81,92].
Lysis curve experiments show that the expression of abiα triggers a premature lysis of
Idefix-infected E. faecalis. A similar phenotype was described in L. lactis, in which lysis, upon infection
by siphophages from the P335 group, occurs earlier in the presence of AbiZ [93]. AbiZ speeds up the
lysis of L. lactis bacteria in which the phage holin and endolysin are expressed, and enhances membrane
permeability of bacteria expressing the phage holin. Durmaz and Klaenhammer propose that AbiZ
interacts with phage holin to accelerate the lysis clock and prevent normal phage multiplication [93].
Abiα and AbiZ do not share any sequence similarity. We were unable to obtain Idefix mutants that were
resistant to Abiα, suggesting a very high efficiency of this Abi system. Based on our results, we can
only speculate that Abiα interferes with lysis, possibly by preventing timely holin and consequently
endolysin(s) actions, as described for AbiZ. Another possibility is that Abiα targets a putative Idefix
holin inhibitor. The holin triggering, which is determinant for optimal burst size, is critically regulated
by the expressed ratio between the holin and its inhibitor. This latter is encoded within the lambda
holin gene, as a separate transcript initiated at a dual-start motif [94,95]. Unlike lambda (and phi29),
the Idefix holin gene does not harbor a dual-start motif and its regulation may be mediated by
the expression of another non-identified Idefix gene, as described in other phages [94,95]. Finally,
premature triggering of lambda holin can also be induced by any poison that efficiently reduces the
proton-motrice force (pmf) of the cytoplasmic membrane [94,95]. Thus, we cannot exclude Abiα
causes a holin-independent reduction of the pmf underlying an early trigger of the holin and/or a
permeabilization of the membrane leading to endolysin release. If this is the case, you might imagine
that Abiαcould be active against a wider range of phages and not only Idefix or related phages. Further
experiments will be needed to test these different hypotheses and complete the characterization of this
defence mechanism.
Genomes of V583 and other MDR E. faecalis isolates have few generalist anti-MGE systems, which
favor horizontal gene transfer and polylysogeny [29]. MDR enterococci may thus provide a suitable
ground for bacteriophages confrontation. Whereas the spread of Idefix infection is thus limited by
V583 prophage 6, it is interesting to note this latter is itself strictly controlled by V583 prophages 3 and
5 that block its excision [43]. This ‘domestication’ could be seen as a way for both prophages to sustain
the specific line of defense conferred by prophage 6 and thus protect themselves and their host from
an external phage ‘attack’.
Beyond the intra-bacteriophage warfare, bacteria are also able to evolve resistance to phages. We
observed that E. faecalis mutants resisting to Idefix infection arose at a high frequency of 1.5 × 10−4 per
generation. The nine Idefix-resistant mutants analyzed had either acquired an IS256 or recombined
between eleven base paires long direct repeats in the epa variable region, indicating that E. faecalis has a
high potential for evolution by recombination. Mutants in glycosyltransferase gene epaX had a 10-fold
defect in Idefix adsorption, whereas mutants in the next o-polymerase gene had a milder adsorption
defect. The fact that all mutations cluster into two genes of the epa variable region underlines the role of
the rhamnopolysaccharide for Idefix adsorption. Epa was recently confirmed as a receptor of E. faecalis
virulent phage NPV1 [96,97], and we provide here the first evidence for a role of Epa decoration chains
in phage/host recognition in enterococci. Rhamnose-rich cell wall polysaccharides (CWPS) and their
structural diversity are important in phage adsorption within lactococci and streptococci [98,99]. In
L. lactis as well, CWPS biosynthesis is encoded on a large chromosomal gene cluster also including a
conserved and a variable region. Based on sequence similarity and difference in the variable region,
L. lactis strains were divided into three groups, and one of them in several subtypes [100]. These
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latter are distinguished by their glycosyltransferase-encoding genes composition and consequent
differences between CWPS structures are critical in determining phage sensitivity [100]. The use of
unconserved sugar decorations of the saccharidic chains as a receptor combined with the presence of a
prophage-encoded Abi system targeting Idefix may explain Idefix very low success in E. faecalis.
5. Conclusions
This study of the Enterococcus infecting Picovirinae Idefix permitted to unveil two resistance
mechanisms against it, one bacterial and the other viral. Bacterial mutations suppressed the Epa
decoration needed for phage adsorption, and the prophage-encoded product Abiα interfered with
Idefix timing of lysis. However, the bacterial line of defence is likely to be counterselected in vivo
as V583 epaX mutants have a defect in mouse gut colonization [49]. In fact, phage selective pressure
might be one of the actors of the observed diversification of the epa locus in enterococci. The viral line
of defence based on Abiα is likely to be more robust, given that no escape mutant could be isolated.
Indeed, Abiα is widespread both in enterococci and in Firmicutes and it may allow to fight against
Picovirinae or other ranges of phages. Somehow, the different families of phages infecting the same
bacterial species are in competition, so that their host resembles a battlefield. It is especially true if
bacteria are devoid of generalist defense systems, as MDR E. faecalis strains tend to be. In this context,
it might be expected that Abi and other specific defensive systems pave prophage genomes, allowing
temperate phages to align their strategy with their host, and fight against virulent phage invaders.
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